FR23C1040I1 - Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline - Google Patents

Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline

Info

Publication number: FR23C1040I1
Authority: FR; France
Prior art keywords: combination; stable crystal; oxoquinoline compound; oxoquinoline; compound
Prior art date: 2004-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR23C1040C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Japan Tobacco Inc

Original Assignee

Japan Tobacco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-20

Filing date

2023-11-02

Publication date

2023-12-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR23C1040(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2023-11-02 Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc

2023-12-29 Publication of FR23C1040I1 publication Critical patent/FR23C1040I1/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

FR23C1040C 2004-05-20 2023-11-02 Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline Active FR23C1040I1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2004150979		2004-05-20
EP05726243A EP1636190B1 (en)	2004-05-20	2005-05-19	Stable crystal of 4-oxoquinoline compound
EP12173572A EP2514746A1 (en)	2004-05-20	2005-05-19	Stable crystal of 4-oxoquinoline compound
PCT/JP2005/009604 WO2005113508A1 (en)	2004-05-20	2005-05-19	Stable crystal of 4-oxoquinoline compound

Publications (1)

Publication Number	Publication Date
FR23C1040I1 true FR23C1040I1 (fr)	2023-12-29

Family

ID=35079161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR23C1040C Active FR23C1040I1 (fr)	2004-05-20	2023-11-02	Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline

Country Status (34)

Country	Link
US (7)	US7635704B2 (ja)
EP (4)	EP2514746A1 (ja)
JP (1)	JP3754064B2 (ja)
KR (1)	KR20080064909A (ja)
CN (1)	CN1956961B (ja)
AR (2)	AR049280A1 (ja)
AU (1)	AU2005245296B2 (ja)
BE (1)	BE2024C511I2 (ja)
BR (1)	BRPI0510114B8 (ja)
CA (1)	CA2566922C (ja)
CY (4)	CY1113010T1 (ja)
DK (2)	DK3281939T3 (ja)
ES (2)	ES2388441T3 (ja)
FI (2)	FI3281939T3 (ja)
FR (1)	FR23C1040I1 (ja)
HK (1)	HK1083341A1 (ja)
HR (2)	HRP20231588T3 (ja)
HU (2)	HUE064615T2 (ja)
IL (1)	IL179250A0 (ja)
LT (1)	LT3281939T (ja)
LU (1)	LUC00334I2 (ja)
MX (1)	MXPA06013405A (ja)
MY (1)	MY134672A (ja)
NO (6)	NO339223B1 (ja)
NZ (1)	NZ551839A (ja)
PE (2)	PE20060358A1 (ja)
PL (2)	PL3281939T3 (ja)
PT (2)	PT3281939T (ja)
RS (2)	RS64845B1 (ja)
RU (1)	RU2330845C1 (ja)
SI (2)	SI1636190T1 (ja)
TW (1)	TWI329015B (ja)
WO (1)	WO2005113508A1 (ja)
ZA (1)	ZA200610647B (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6891227B2 (en)	2002-03-20	2005-05-10	International Business Machines Corporation	Self-aligned nanotube field effect transistor and method of fabricating same
US7176220B2 (en) *	2002-11-20	2007-02-13	Japan Tobacco Inc.	4-oxoquinoline compound and use thereof as pharmaceutical agent
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
WO2007063869A1 (ja) *	2005-11-30	2007-06-07	Japan Tobacco Inc.	高純度キノロン化合物の製造方法
US20090233964A1 (en) *	2005-12-30	2009-09-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
SG170795A1 (en) *	2005-12-30	2011-05-30	Gilead Sciences Inc	Methods for improving the pharmacokinetics of hiv integrase inhibitors
AU2013203476C1 (en) *	2005-12-30	2016-11-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
JP2009525261A (ja) *	2006-02-01	2009-07-09	日本たばこ産業株式会社	レトロウイルス感染症の治療のための、６−（３−クロロ−２−フルオロベンジル）−１−［（２ｓ）−１−ヒドロキシ−３−メチルブタン−２−イル］−７−メトキシ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸またはその塩の使用
WO2007092802A1 (en) *	2006-02-09	2007-08-16	Boehringer Ingelheim International Gmbh	Method for treating hiv infection through co-administration of tipranavir and gs 9137
PL1992607T3 (pl) *	2006-03-06	2015-05-29	Japan Tobacco Inc	Sposób wytwarzania związku 4-oksochinolinowego
US8420821B2 (en)	2006-03-06	2013-04-16	Japan Tobacco Inc.	Process for production of 4-oxoquinoline compound
WO2008010921A2 (en)	2006-07-07	2008-01-24	Gilead Sciences, Inc.	Modulators of pharmacokinetic properties of therapeutics
ES2536923T3 (es)	2006-09-12	2015-05-29	Gilead Sciences, Inc.	Proceso e intermedios para preparar inhibidores de la integrasa del VIH
KR101577698B1 (ko) *	2007-02-23	2015-12-15	길리애드 사이언시즈, 인코포레이티드	치료제의 약동학적 특성의 조절제
CN103356622A (zh) *	2007-06-29	2013-10-23	吉里德科学公司	治疗用组合物及其用途
AP2965A (en) *	2007-06-29	2014-09-30	Gilead Sciences Inc	Therapeutic compositions and the use thereof
AR068403A1 (es) *	2007-09-11	2009-11-18	Gilead Sciences Inc	Proceso e intermediarios para la preparacion de inhibidores de integrasa
AU2009242451C1 (en)	2008-05-02	2017-05-18	Gilead Sciences, Inc.	The use of solid carrier particles to improve the processability of a pharmaceutical agent
JP5611242B2 (ja)	2009-02-06	2014-10-22	ギリアードサイエンシーズ，インコーポレイテッド	併用治療のための錠剤
WO2010137032A2 (en) *	2009-05-14	2010-12-02	Matrix Laboratories Ltd.	Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts
WO2011004389A2 (en) *	2009-06-18	2011-01-13	Matrix Laboratories Ltd	An improved process for the preparation of elvitegravir
CN102212032B (zh) *	2011-04-20	2013-07-31	复旦大学	一种5-羟基喹诺酮类衍生物及其制备方法和用途
WO2014008458A2 (en)	2012-07-06	2014-01-09	Genentech, Inc.	N-substituted benzamides and methods of use thereof
JP6147856B2 (ja)	2012-08-03	2017-06-14	ギリアードサイエンシーズ，インコーポレイテッド	インテグラーゼインヒビターを調製するためのプロセスおよび中間体
CN103819402B (zh) *	2012-11-17	2016-03-30	上海迪赛诺化学制药有限公司	埃替拉韦中间体及其制备方法和应用
CN103864682B (zh) *	2012-12-18	2016-12-28	上海迪赛诺化学制药有限公司	一种制备iii型埃替拉韦晶体的方法
TWI752457B (zh)	2012-12-21	2022-01-11	美商基利科學股份有限公司	多環胺甲醯基吡啶酮化合物及其醫藥用途
PL3019503T3 (pl)	2013-07-12	2018-01-31	Gilead Sciences Inc	Policykliczne związki karbamoilopirydonowe i ich zastosowanie do leczenia infekcji hiv
NO2865735T3 (ja)	2013-07-12	2018-07-21
CN105315203A (zh) *	2014-06-06	2016-02-10	上海迪赛诺化学制药有限公司	一种v型埃替拉韦晶体及其制备方法
NO2717902T3 (ja)	2014-06-20	2018-06-23
TW201613936A (en)	2014-06-20	2016-04-16	Gilead Sciences Inc	Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI677489B (zh)	2014-06-20	2019-11-21	美商基利科學股份有限公司	多環型胺甲醯基吡啶酮化合物之合成
TWI695003B (zh)	2014-12-23	2020-06-01	美商基利科學股份有限公司	多環胺甲醯基吡啶酮化合物及其醫藥用途
KR20190057158A (ko)	2015-04-02	2019-05-27	길리애드 사이언시즈, 인코포레이티드	폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도
CN106008195B (zh) *	2016-05-19	2018-08-03	绍兴文理学院	一种2，4-二氟-5-碘苯甲酸的制备方法
EP3984536A1 (en) *	2020-10-19	2022-04-20	Centre national de la recherche scientifique	Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3472859A (en) *	1966-11-01	1969-10-14	Sterling Drug Inc	1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
JPS567162B1 (ja)	1970-09-14	1981-02-16
JPS4826772A (ja)	1971-08-11	1973-04-09
JPS6450979A (en)	1987-08-21	1989-02-27	Hitachi Shipbuilding Eng Co	Method for discriminating whistle sound
JPH0651229B2 (ja)	1989-07-31	1994-07-06	新日本製鐵株式会社	プラズマアーク溶接方法および装置
IL100555A (en)	1991-02-07	2000-08-31	Hoechst Marion Roussel Inc	N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
JP2993316B2 (ja)	1992-05-27	1999-12-20	宇部興産株式会社	アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
NO304832B1 (no) *	1992-05-27	1999-02-22	Ube Industries	Aminokinolonderivater samt middel mot HIV
JPH06199835A (ja)	1993-01-08	1994-07-19	Hokuriku Seiyaku Co Ltd	８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
JPH06271568A (ja)	1993-03-22	1994-09-27	Hokuriku Seiyaku Co Ltd	７−フェニルピペラジニルキノリン−３−カルボン酸誘導体
JP2930539B2 (ja)	1994-07-18	1999-08-03	三共株式会社	トリフルオロメチルキノリンカルボン酸誘導体
WO1996002512A1 (fr) *	1994-07-18	1996-02-01	Ube Industries, Ltd.	Acide du type trifluoromethylquinoleinecarboxylique
JPH0826772A (ja)	1994-07-22	1996-01-30	Sony Corp	融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
ES2171260T3 (es)	1996-04-12	2002-09-01	Us Gov Health & Human Serv	Compuestos derivados de acridona utiles como agentes antineoplasicos y antirretroviricos.
FR2761687B1 (fr) *	1997-04-08	2000-09-15	Centre Nat Rech Scient	Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
JP3776203B2 (ja)	1997-05-13	2006-05-17	第一製薬株式会社	Ｉｃａｍ−１産生阻害剤
GB9721964D0 (en) *	1997-10-16	1997-12-17	Pfizer Ltd	Isoquinolines
US6399629B1 (en)	1998-06-01	2002-06-04	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
US6248736B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
US6248739B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	Quinolinecarboxamides as antiviral agents
PE20011349A1 (es)	2000-06-16	2002-01-19	Upjohn Co	1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
US6559145B2 (en) *	2000-07-12	2003-05-06	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
AU2002230392A1 (en)	2000-10-12	2002-05-15	Merck & Co., Inc.	AZA-and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors
JP2004517860A (ja)	2000-10-12	2004-06-17	メルク　エンド　カムパニー　インコーポレーテッド	Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
US7148237B2 (en) *	2001-03-01	2006-12-12	Shionogi & Co., Ltd.	Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
JP2002293745A (ja)	2001-03-29	2002-10-09	St Marianna Univ School Of Medicine	慢性関節リウマチ治療剤
US20030138483A1 (en) *	2001-05-25	2003-07-24	Sergio Petriconi	Soft elastic capsules and compositions thereof
US6627646B2 (en) *	2001-07-17	2003-09-30	Sepracor Inc.	Norastemizole polymorphs
FR2827600A1 (fr)	2001-07-20	2003-01-24	Lipha	Derives acides de quinolone et leurs applications en therapeutique
JP4035765B2 (ja)	2002-10-31	2008-01-23	横河電機株式会社	フーリエ変換型赤外線分光計
US7176220B2 (en) *	2002-11-20	2007-02-13	Japan Tobacco Inc.	4-oxoquinoline compound and use thereof as pharmaceutical agent
JP3567162B1 (ja)	2002-11-20	2004-09-22	日本たばこ産業株式会社	４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
US7531554B2 (en) *	2004-05-20	2009-05-12	Japan Tobacco Inc.	4-oxoquinoline compound and use thereof as HIV integrase inhibitor
EP2332538A1 (en) *	2004-05-21	2011-06-15	Japan Tobacco, Inc.	Combinations comprising a 4-isoquinolone derivative and anti-HIV agents

2005
- 2005-05-18 MY MYPI20052258A patent/MY134672A/en unknown
- 2005-05-19 ES ES05726243T patent/ES2388441T3/es active Active
- 2005-05-19 LT LTEP17186674.2T patent/LT3281939T/lt unknown
- 2005-05-19 HU HUE17186674A patent/HUE064615T2/hu unknown
- 2005-05-19 FI FIEP17186674.2T patent/FI3281939T3/fi active
- 2005-05-19 HR HRP20231588TT patent/HRP20231588T3/hr unknown
- 2005-05-19 KR KR1020087014768A patent/KR20080064909A/ko not_active Withdrawn
- 2005-05-19 RS RS20231092A patent/RS64845B1/sr unknown
- 2005-05-19 ES ES17186674T patent/ES2960824T3/es active Active
- 2005-05-19 EP EP12173572A patent/EP2514746A1/en not_active Withdrawn
- 2005-05-19 PT PT171866742T patent/PT3281939T/pt unknown
- 2005-05-19 MX MXPA06013405A patent/MXPA06013405A/es active IP Right Grant
- 2005-05-19 PL PL17186674.2T patent/PL3281939T3/pl unknown
- 2005-05-19 PL PL05726243T patent/PL1636190T3/pl unknown
- 2005-05-19 JP JP2005147219A patent/JP3754064B2/ja active Active
- 2005-05-19 NZ NZ551839A patent/NZ551839A/en unknown
- 2005-05-19 DK DK17186674.2T patent/DK3281939T3/da active
- 2005-05-19 RU RU2006145302/04A patent/RU2330845C1/ru active
- 2005-05-19 CA CA2566922A patent/CA2566922C/en active Active
- 2005-05-19 EP EP17186674.2A patent/EP3281939B1/en active Active
- 2005-05-19 CN CN2005800161426A patent/CN1956961B/zh active Active
- 2005-05-19 SI SI200531572T patent/SI1636190T1/sl unknown
- 2005-05-19 DK DK05726243.8T patent/DK1636190T3/da active
- 2005-05-19 ZA ZA200610647A patent/ZA200610647B/en unknown
- 2005-05-19 SI SI200532315T patent/SI3281939T1/sl unknown
- 2005-05-19 WO PCT/JP2005/009604 patent/WO2005113508A1/en active Application Filing
- 2005-05-19 PT PT05726243T patent/PT1636190E/pt unknown
- 2005-05-19 TW TW094116234A patent/TWI329015B/zh active
- 2005-05-19 AR ARP050102058A patent/AR049280A1/es not_active Application Discontinuation
- 2005-05-19 BR BRPI0510114A patent/BRPI0510114B8/pt active IP Right Grant
- 2005-05-19 AU AU2005245296A patent/AU2005245296B2/en active Active
- 2005-05-19 EP EP05726243A patent/EP1636190B1/en active Active
- 2005-05-19 RS RS20120306A patent/RS52375B/en unknown
- 2005-05-19 EP EP23203885.1A patent/EP4299563A3/en active Pending
- 2005-05-20 US US11/133,471 patent/US7635704B2/en active Active
- 2005-05-20 PE PE2005000561A patent/PE20060358A1/es active IP Right Grant
- 2005-05-20 PE PE2011002129A patent/PE20120361A1/es active IP Right Grant
2006
- 2006-05-11 HK HK06105469.5A patent/HK1083341A1/xx unknown
- 2006-11-14 IL IL179250A patent/IL179250A0/en active IP Right Grant
- 2006-12-14 NO NO20065790A patent/NO339223B1/no unknown
2009
- 2009-08-10 US US12/538,694 patent/US8981103B2/en active Active
2012
- 2012-07-11 CY CY20121100621T patent/CY1113010T1/el unknown
- 2012-08-24 HR HRP20120681TT patent/HRP20120681T1/hr unknown
2014
- 2014-04-25 AR ARP140101722A patent/AR096100A2/es active IP Right Grant
2015
- 2015-01-09 US US14/593,946 patent/US20150361044A1/en not_active Abandoned
2016
- 2016-08-12 NO NO20161297A patent/NO20161297A1/no not_active Application Discontinuation
2017
- 2017-03-01 US US15/447,007 patent/US20180029989A1/en not_active Abandoned
2018
- 2018-07-20 US US16/041,458 patent/US20190185433A1/en not_active Abandoned
2019
- 2019-01-15 NO NO20190051A patent/NO20190051A1/no not_active Application Discontinuation
2020
- 2020-08-04 NO NO20200873A patent/NO20200873A1/no not_active Application Discontinuation
2021
- 2021-08-24 US US17/445,817 patent/US20220235009A1/en not_active Abandoned
2022
- 2022-06-17 NO NO20220690A patent/NO20220690A1/no not_active Application Discontinuation
2023
- 2023-08-25 NO NO20230913A patent/NO347902B1/no unknown
- 2023-09-28 CY CY2015009C patent/CY2015009I2/el unknown
- 2023-11-02 FR FR23C1040C patent/FR23C1040I1/fr active Active
- 2023-12-05 CY CY20231100714T patent/CY1126560T1/el unknown
2024
- 2024-03-14 LU LU00334C patent/LUC00334I2/fr unknown
- 2024-03-15 BE BE2024C511C patent/BE2024C511I2/nl unknown
- 2024-03-19 CY CY2024008C patent/CY2024008I2/el unknown
- 2024-03-20 FI FIC20240008C patent/FIC20240008I1/fi unknown
- 2024-03-20 HU HUS2400006C patent/HUS2400006I1/hu unknown
- 2024-04-12 US US18/634,451 patent/US20250091995A1/en active Pending

Also Published As

Publication number	Publication date
RS64845B1 (sr)	2023-12-29
US20190185433A1 (en)	2019-06-20
CN1956961B (zh)	2010-05-26
PL3281939T3 (pl)	2024-03-18
KR20080064909A (ko)	2008-07-09
NO20190051A1 (no)	2007-02-07
US20220235009A1 (en)	2022-07-28
NO20065790L (no)	2007-02-07
CA2566922A1 (en)	2005-12-01
RU2330845C1 (ru)	2008-08-10
NO20220690A1 (no)	2007-02-07
PE20060358A1 (es)	2006-05-12
PT3281939T (pt)	2023-11-22
NO339223B1 (no)	2016-11-21
BRPI0510114B8 (pt)	2021-05-25
US20250091995A1 (en)	2025-03-20
IL179250A0 (en)	2007-03-08
BE2024C511I2 (ja)	2024-10-08
TWI329015B (en)	2010-08-21
NZ551839A (en)	2009-11-27
RS52375B (en)	2012-12-31
NO20200873A1 (no)	2007-02-07
CN1956961A (zh)	2007-05-02
EP3281939A1 (en)	2018-02-14
HRP20120681T1 (hr)	2012-09-30
ZA200610647B (en)	2008-06-25
JP3754064B2 (ja)	2006-03-08
AR049280A1 (es)	2006-07-12
HUE064615T2 (hu)	2024-04-28
AU2005245296B2 (en)	2010-08-12
LT3281939T (lt)	2023-11-27
EP4299563A3 (en)	2024-02-28
EP3281939B1 (en)	2023-10-18
NO20161297A1 (no)	2007-02-07
NO20230913A1 (no)	2007-02-07
CY2015009I1 (el)	2024-09-20
BRPI0510114A (pt)	2007-09-25
PE20120361A1 (es)	2012-05-03
CY1113010T1 (el)	2016-04-13
SI3281939T1 (sl)	2024-02-29
US8981103B2 (en)	2015-03-17
DK3281939T3 (da)	2024-01-22
EP1636190A1 (en)	2006-03-22
WO2005113508A1 (en)	2005-12-01
EP4299563A2 (en)	2024-01-03
CY2024008I1 (el)	2024-09-20
PL1636190T3 (pl)	2012-10-31
LUC00334I2 (ja)	2024-07-01
EP1636190B1 (en)	2012-06-27
US20060030710A1 (en)	2006-02-09
SI1636190T1 (sl)	2012-09-28
US20100204271A1 (en)	2010-08-12
CA2566922C (en)	2011-01-11
AU2005245296A1 (en)	2005-12-01
HRP20231588T3 (hr)	2024-03-15
BRPI0510114B1 (pt)	2020-09-15
JP2006001927A (ja)	2006-01-05
HK1083341A1 (en)	2006-06-30
ES2388441T3 (es)	2012-10-15
US20150361044A1 (en)	2015-12-17
US7635704B2 (en)	2009-12-22
MXPA06013405A (es)	2007-03-01
FIC20240008I1 (fi)	2024-03-20
CY1126560T1 (el)	2024-09-20
CY2024008I2 (el)	2024-09-20
PT1636190E (pt)	2012-08-20
HUS2400006I1 (hu)	2024-04-28
NO347902B1 (no)	2024-05-06
EP2514746A1 (en)	2012-10-24
TW200600097A (en)	2006-01-01
DK1636190T3 (da)	2012-09-24
ES2960824T3 (es)	2024-03-06
AR096100A2 (es)	2015-12-09
FI3281939T3 (fi)	2023-10-23
US20180029989A1 (en)	2018-02-01
MY134672A (en)	2007-12-31
CY2015009I2 (el)	2024-09-20

Publication	Publication Date	Title
FR23C1040I1 (fr)	2023-12-29	Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline
LTC1778013I2 (lt)	2018-08-10	Fungicidų kompozicijos
DE50309032D1 (de)	2008-03-06	Fungizide wirkstoffkombinationen
DE50309693D1 (de)	2008-06-05	Fungizide wirkstoffkombination
EP1849305A4 (en)	2010-08-11	HIDE DISORDER
DE602005015215D1 (de)	2009-08-13	Orthosubstituierte aryl- oder heteroarylamidverbindungen
EP1911743A4 (en)	2010-09-01	CYCLIC AMINE COMPOUND
ZA200708811B (en)	2009-01-28	Use of a sulfonamide compound for improving the pharma-cokinetics of a drug
NO20080412L (no)	2008-03-18	Ny fysiologisk forbindelse Nesfatin, forbindelse relevant dertil og anvendelse av forbindelsene
EP1813875A4 (en)	2011-03-02	INDOOR UNIT FOR AIR CONDITIONING
EP1727065A4 (en)	2010-05-05	Event sequencer
DE502004010641D1 (de)	2010-03-04	Atemschutzmaske
EP1821084A4 (en)	2011-01-26	COMBINATION COMPENSATION DEVICE
ITRM20040607A1 (it)	2005-03-15	Analoghi della dermorfina ad attivita' analgesica.
ITUD20040054A1 (it)	2004-06-26	Procedimento per la realizzazione di un
EP1889841A4 (en)	2010-04-07	CRYSTAL OF A SALT OF A BENZIMIDAZOLE COMPOUND
DE602004026790D1 (de)	2010-06-02	Stabilisierte propylbromidzusammensetzungen
FR2870760B1 (fr)	2008-04-25	Huisserie metallique d'un nouveau type
ITMI20040230A1 (it)	2004-05-12	Composti ad attivita' antitumorale
DE502005001784D1 (de)	2007-12-06	Fungizide wirkstoffkombinationen
FI20040178A0 (fi)	2004-02-06	Monitelakalanteri
DE602005012130D1 (de)	2009-02-12	Pulmonäre verabreichung einer antithrombotischen verbindung
SE0202115D0 (sv)	2002-07-08	Use of a composition
UA10016S (uk)	2005-03-15	Скляний циферблат для настінного годинника «матрац червоний»
UA9248S (uk)	2004-08-16	Календар історичних подій